What happened?
ECDC reports an ongoing Ebola disease outbreak caused by Bundibugyo virus centred in the Democratic Republic of the Congo (DRC). As of 21–22 October 2026 the DRC reported 9,704 confirmed cases and 4,687 deaths; neighbouring countries have detected imported or linked cases, including nine confirmed in Kenya and one imported case in Nigeria.
Why does it matter?
ECDC judges the likelihood of infection for EU/EEA residents or travellers in affected DRC areas as low, and the chance of importation and onward transmission in the EU/EEA as very low. Risk estimates reflect current case numbers, travel patterns and control measures, but carry uncertainty.
How to interpret the evidence
The report notes substantial uncertainty due to incomplete contact follow-up, humanitarian and security challenges, and likely under‑ascertainment in affected provinces. It does not assume availability of Bundibugyo‑specific vaccines or treatments in the EU; applicability to Malta/EU depends on case exportation and national preparedness rather than current local transmission.
What remains uncertain?
This update does not indicate widespread risk inside the EU/EEA, nor does it imply licensed vaccines or specific therapeutics exist for Bundibugyo virus. It does not recommend changes to routine care in EU settings and does not replace national public health guidance or travel advisories.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.
This summary was prepared with AI assistance and checked automatically against the linked primary source. It has not been individually reviewed by a clinician.